RU2017112735A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017112735A3 RU2017112735A3 RU2017112735A RU2017112735A RU2017112735A3 RU 2017112735 A3 RU2017112735 A3 RU 2017112735A3 RU 2017112735 A RU2017112735 A RU 2017112735A RU 2017112735 A RU2017112735 A RU 2017112735A RU 2017112735 A3 RU2017112735 A3 RU 2017112735A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161475908P | 2011-04-15 | 2011-04-15 | |
| US61/475,908 | 2011-04-15 | ||
| US13/211,101 US8680086B2 (en) | 2011-04-15 | 2011-08-16 | Methods for chronic pain management and treatment using HCG |
| US13/211,101 | 2011-08-16 | ||
| US13/311,250 US20120265129A1 (en) | 2011-04-15 | 2011-12-05 | Methods for Chronic Pain Management and Treatment using HCG |
| US13/311,250 | 2011-12-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013150024/15A Division RU2013150024A (ru) | 2011-04-15 | 2012-04-16 | Способы контроля и лечения хронической боли с применением hcg |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017112735A RU2017112735A (ru) | 2019-01-25 |
| RU2017112735A3 true RU2017112735A3 (ru) | 2020-08-03 |
| RU2755938C2 RU2755938C2 (ru) | 2021-09-23 |
Family
ID=47006948
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013150024/15A RU2013150024A (ru) | 2011-04-15 | 2012-04-16 | Способы контроля и лечения хронической боли с применением hcg |
| RU2017112735A RU2755938C2 (ru) | 2011-04-15 | 2012-04-16 | Способы контроля и лечения хронической боли с применением hcg |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013150024/15A RU2013150024A (ru) | 2011-04-15 | 2012-04-16 | Способы контроля и лечения хронической боли с применением hcg |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20120265129A1 (ru) |
| EP (1) | EP2696885B1 (ru) |
| JP (3) | JP2014510797A (ru) |
| KR (1) | KR102029187B1 (ru) |
| CN (2) | CN107469072A (ru) |
| AU (1) | AU2012242443C1 (ru) |
| BR (1) | BR112013026284B1 (ru) |
| CA (1) | CA2864875C (ru) |
| DK (1) | DK2696885T3 (ru) |
| MX (1) | MX359672B (ru) |
| RU (2) | RU2013150024A (ru) |
| WO (1) | WO2012142609A1 (ru) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
| US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
| BR112015008753A2 (pt) | 2012-10-18 | 2017-07-04 | Neuralight Hd Llc | tratamento de depressão e ptsd |
| CN107206057A (zh) * | 2014-11-12 | 2017-09-26 | 纽瑞莱特Hd有限公司 | 用hcg处理和治疗慢性疼痛的方法 |
| US10143625B2 (en) | 2015-03-17 | 2018-12-04 | Recon Therapeutics, Inc. | Pharmaceutical reconstitution |
| US20220175701A1 (en) * | 2020-12-08 | 2022-06-09 | Therapeutic Solutions International, Inc. | Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approaches |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4689222A (en) | 1985-01-18 | 1987-08-25 | Mcmichael John | Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| IL86799A (en) * | 1987-07-02 | 1993-03-15 | Kabi Pharmacia Ab | Method and device for injection |
| US5384132A (en) | 1990-03-20 | 1995-01-24 | Akzo N.V. | Stabilized gonadotropin containing preparations |
| US5677275A (en) | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
| AU707796B2 (en) | 1995-03-21 | 1999-07-22 | Merck Serono Sa | HCG liquid formulations |
| TW518235B (en) | 1997-01-15 | 2003-01-21 | Akzo Nobel Nv | A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage |
| US6488649B1 (en) | 1998-11-24 | 2002-12-03 | Edward M. Lichten | Implant device |
| US6417184B1 (en) * | 2000-09-19 | 2002-07-09 | David M. Ockert | Triple drug therapy for the treatment and prevention of acute or chronic pain |
| US20020123670A1 (en) * | 2000-12-29 | 2002-09-05 | Goetzke Gary A. | Chronic pain patient diagnostic system |
| MEP39208A (en) * | 2001-09-12 | 2011-02-10 | Merck Serono Sa | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
| US20080318871A1 (en) * | 2001-12-21 | 2008-12-25 | Khan Nisar A | Treatment of neurological disorders |
| US7101847B2 (en) * | 2002-10-11 | 2006-09-05 | Milkhaus Laboratory, Inc. | Method of treating chronic pelvic pain syndrome by administration of chorionic gonadotropin |
| DE60325275D1 (de) | 2003-02-07 | 2009-01-22 | Austria Wirtschaftsservice Gmbh | Verwendung des menschlichen choriongonadotropins in der behandlung von endometriose-symptomen |
| US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
| JP2009530234A (ja) * | 2006-03-17 | 2009-08-27 | ステム セル セラピューティクス コーポレイション | 神経変性疾患の治療のためのｌｈまたはｈｃｇ、およびｅｐｏについての投与レジメン |
| CN1865944A (zh) * | 2006-06-15 | 2006-11-22 | 福州大学 | 无创定量hcg检测方法 |
| US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
| US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
-
2011
- 2011-12-05 US US13/311,250 patent/US20120265129A1/en not_active Abandoned
-
2012
- 2012-04-16 BR BR112013026284-2A patent/BR112013026284B1/pt active IP Right Grant
- 2012-04-16 JP JP2014505405A patent/JP2014510797A/ja active Pending
- 2012-04-16 DK DK12771099.4T patent/DK2696885T3/da active
- 2012-04-16 MX MX2013012078A patent/MX359672B/es active IP Right Grant
- 2012-04-16 CN CN201710686084.2A patent/CN107469072A/zh active Pending
- 2012-04-16 AU AU2012242443A patent/AU2012242443C1/en active Active
- 2012-04-16 CN CN201280028332.XA patent/CN103596647A/zh active Pending
- 2012-04-16 EP EP12771099.4A patent/EP2696885B1/en active Active
- 2012-04-16 RU RU2013150024/15A patent/RU2013150024A/ru not_active Application Discontinuation
- 2012-04-16 KR KR1020137030242A patent/KR102029187B1/ko active IP Right Grant
- 2012-04-16 CA CA2864875A patent/CA2864875C/en active Active
- 2012-04-16 WO PCT/US2012/033828 patent/WO2012142609A1/en active Application Filing
- 2012-04-16 RU RU2017112735A patent/RU2755938C2/ru active
- 2012-10-02 US US13/633,739 patent/US8680088B2/en active Active
-
2014
- 2014-03-18 US US14/218,448 patent/US20150057224A1/en not_active Abandoned
-
2017
- 2017-04-20 JP JP2017083287A patent/JP6571713B2/ja active Active
-
2019
- 2019-08-08 JP JP2019145911A patent/JP2019189660A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP6571713B2 (ja) | 2019-09-04 |
| JP2014510797A (ja) | 2014-05-01 |
| JP2019189660A (ja) | 2019-10-31 |
| CN103596647A (zh) | 2014-02-19 |
| US20130196914A1 (en) | 2013-08-01 |
| RU2755938C2 (ru) | 2021-09-23 |
| MX359672B (es) | 2018-10-05 |
| CA2864875A1 (en) | 2012-10-18 |
| AU2012242443B2 (en) | 2015-12-10 |
| US20150057224A1 (en) | 2015-02-26 |
| WO2012142609A1 (en) | 2012-10-18 |
| CN107469072A (zh) | 2017-12-15 |
| BR112013026284B1 (pt) | 2022-09-20 |
| US20120265129A1 (en) | 2012-10-18 |
| CA2864875C (en) | 2020-08-18 |
| AU2012242443C1 (en) | 2016-06-16 |
| JP2017206500A (ja) | 2017-11-24 |
| DK2696885T3 (da) | 2020-02-03 |
| RU2013150024A (ru) | 2015-05-20 |
| US8680088B2 (en) | 2014-03-25 |
| KR102029187B1 (ko) | 2019-10-07 |
| MX2013012078A (es) | 2015-08-06 |
| BR112013026284A2 (pt) | 2020-08-11 |
| EP2696885A1 (en) | 2014-02-19 |
| AU2012242443A1 (en) | 2013-05-02 |
| EP2696885B1 (en) | 2019-11-20 |
| KR20140043731A (ko) | 2014-04-10 |
| EP2696885A4 (en) | 2014-11-05 |
| RU2017112735A (ru) | 2019-01-25 |